A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data.
Saved in:
| Title: | A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data. |
|---|---|
| Authors: | Gatto NM; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Kaiser Permanente, Bernard Tyson School of Medicine, Pasadena, California, USA., Cronkite DJ; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA., Wartko PD; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Ball R; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Carrell DS; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA., Eniafe R; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Desai R; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA., Floyd JS; Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington, USA., Lee T; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Nelson JC; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA., Shebl FM; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Schoeplein R; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA., Toh S; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA., Zhang M; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA., Dublin S; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Kaiser Permanente, Bernard Tyson School of Medicine, Pasadena, California, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA., Hernández-Muñoz JJ; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA. |
| Source: | Pharmacoepidemiology and drug safety [Pharmacoepidemiol Drug Saf] 2026 Mar; Vol. 35 (3), pp. e70346. |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Wiley Country of Publication: England NLM ID: 9208369 Publication Model: Print Cited Medium: Internet ISSN: 1099-1557 (Electronic) Linking ISSN: 10538569 NLM ISO Abbreviation: Pharmacoepidemiol Drug Saf Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
| FullText | Text: Availability: 0 |
|---|---|
| Header | DbId: mdl DbLabel: MEDLINE Ultimate An: 41820261 AccessLevel: 2 PubType: Academic Journal PubTypeId: academicJournal PreciseRelevancyScore: 0 |
| IllustrationInfo | |
| Items | – Name: Title Label: Title Group: Ti Data: A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data. – Name: Author Label: Authors Group: Au Data: <searchLink fieldCode="AU" term="%22Gatto+NM%22">Gatto NM</searchLink>; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Kaiser Permanente, Bernard Tyson School of Medicine, Pasadena, California, USA.<br /><searchLink fieldCode="AU" term="%22Cronkite+DJ%22">Cronkite DJ</searchLink>; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Wartko+PD%22">Wartko PD</searchLink>; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Ball+R%22">Ball R</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Carrell+DS%22">Carrell DS</searchLink>; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Eniafe+R%22">Eniafe R</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Desai+R%22">Desai R</searchLink>; Division of Pharmacoepidemiology and Pharmacoeconomics, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Floyd+JS%22">Floyd JS</searchLink>; Departments of Medicine and Epidemiology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Lee+T%22">Lee T</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Nelson+JC%22">Nelson JC</searchLink>; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Shebl+FM%22">Shebl FM</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Schoeplein+R%22">Schoeplein R</searchLink>; Department of Population Medicine, Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Toh+S%22">Toh S</searchLink>; Department of Population Medicine, Harvard Pilgrim Health Care Institute and Harvard Medical School, Boston, Massachusetts, USA.<br /><searchLink fieldCode="AU" term="%22Zhang+M%22">Zhang M</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.<br /><searchLink fieldCode="AU" term="%22Dublin+S%22">Dublin S</searchLink>; Kaiser Permanente Washington, Health Research Institute, Seattle, Washington, USA.; Kaiser Permanente, Bernard Tyson School of Medicine, Pasadena, California, USA.; Department of Epidemiology, University of Washington, Seattle, Washington, USA.<br /><searchLink fieldCode="AU" term="%22Hernández-Muñoz+JJ%22">Hernández-Muñoz JJ</searchLink>; Office of Surveillance and Epidemiology, Center for Drug Evaluation and Research, U.S. Food and Drug Administration, Silver Spring, Maryland, USA. – Name: TitleSource Label: Source Group: Src Data: <searchLink fieldCode="JN" term="%229208369%22">Pharmacoepidemiology and drug safety</searchLink> [Pharmacoepidemiol Drug Saf] 2026 Mar; Vol. 35 (3), pp. e70346. – Name: TypePub Label: Publication Type Group: TypPub Data: Journal Article – Name: TitleSource Label: Journal Info Group: Src Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22Wiley%22">Wiley </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>9208369 <i>Publication Model: </i>Print <i>Cited Medium: </i>Internet <i>ISSN: </i>1099-1557 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2210538569%22">10538569 </searchLink><i>NLM ISO Abbreviation: </i>Pharmacoepidemiol Drug Saf <i>Subsets: </i>MEDLINE |
| PLink | https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=41820261 |
| RecordInfo | BibRecord: BibEntity: Identifiers: – Type: doi Value: 10.1002/pds.70346 Languages: – Code: eng Text: English PhysicalDescription: Pagination: StartPage: e70346 Titles: – TitleFull: A Systematic Process for Assessing Fitness-for-Purpose of Health Outcomes for Computable Phenotyping With Electronic Health Record Data. Type: main BibRelationships: HasContributorRelationships: – PersonEntity: Name: NameFull: Gatto NM – PersonEntity: Name: NameFull: Cronkite DJ – PersonEntity: Name: NameFull: Wartko PD – PersonEntity: Name: NameFull: Ball R – PersonEntity: Name: NameFull: Carrell DS – PersonEntity: Name: NameFull: Eniafe R – PersonEntity: Name: NameFull: Desai R – PersonEntity: Name: NameFull: Floyd JS – PersonEntity: Name: NameFull: Lee T – PersonEntity: Name: NameFull: Nelson JC – PersonEntity: Name: NameFull: Shebl FM – PersonEntity: Name: NameFull: Schoeplein R – PersonEntity: Name: NameFull: Toh S – PersonEntity: Name: NameFull: Zhang M – PersonEntity: Name: NameFull: Dublin S – PersonEntity: Name: NameFull: Hernández-Muñoz JJ IsPartOfRelationships: – BibEntity: Dates: – D: 01 M: 03 Text: 2026 Mar Type: published Y: 2026 Identifiers: – Type: issn-electronic Value: 1099-1557 Numbering: – Type: volume Value: 35 – Type: issue Value: 3 Titles: – TitleFull: Pharmacoepidemiology and drug safety Type: main |
| ResultId | 1 |